Jivi is a medicine used to treat and prevent bleeding in patients with haemophilia A, an inherited bleeding disorder caused by lack of a clotting protein called factor VIII. Jivi can be used in adults and children from 12 years of age who have been treated previously. Jivi contains the active substance damoctocog alfa pegol.
Therapeutic Indication
### Therapeutic indication Treatment and prophylaxis of bleeding in previously treated patients ? 12 years of age with haemophilia A (congenital factor VIII deficiency).
Therapeutic Area (MeSH)
ATC Code
B02BD02
ATC Item
coagulation factor VIII
Pharmacotherapeutic Group
Antihemorrhagics
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| Damoctocog alfa pegol | N/A | Damoctocog alfa pegol |
EMA Name
Jivi
Medicine Name
Jivi
Aliases
N/ANo risk management plan link.
